Cannabinoid Biosciences, Inc. (PIFR)

OTCMKTS · Delayed Price · Currency is USD
0.0016
+0.0001 (6.67%)
At close: May 12, 2026
Market Cap93.69K -87.0%
Revenue (ttm)n/a +35.3%
Net Incomen/a
EPSn/a
Shares Out 58.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,000
Open0.0016
Previous Close0.0015
Day's Range0.0016 - 0.0016
52-Week Range0.0004 - 0.0040
Beta-0.48
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Cannabinoid Biosciences

Cannabinoid Biosciences, Inc. develops biopharmaceutical products from proprietary cannabinoids and synthetic cannabinoids for the treatement of specific diseases. The company was founded in 2014 and is headquartered in Los Angeles, California. [Read more]

Founded 2014
Country United States
Stock Exchange OTCMKTS
Ticker Symbol PIFR
Full Company Profile

Financial Performance

In 2009, PIFR's revenue was $494,410, an increase of 29.22% compared to the previous year's $382,618. Losses were -$119,161, -13.05% less than in 2008.

Financial Statements

News

Premier Information Management, Inc. Partners with Modern Products Group for Acquisitions in Nutraceutical Markets

Torrance, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Premier Information Management Inc, a public company (OTC: PIFR), is planning a series of acquisitions to grow a manufacturing and distribution comp...

4 years ago - GlobeNewsWire

Premier Information Management, Inc. Announces Reverse Merger With Cannabinoid Biosciences, Inc.

TORRANCE, May 13, 2021 (GLOBE NEWSWIRE) -- Premier Information Management, Inc. (OTC: PIFR) announced today that it has entered into a reverse merger agreement with Cannabinoid Biosciences, Inc. a Cal...

5 years ago - GlobeNewsWire